Patients can use myMedidata Registries to learn more about clinical trial opportunities and actively participate throughout their clinical trial journey, according to the company. It provides continuous support for patients in and out of a trial, Medidata said.

For trial sponsors, myMedidata Registries serves as a unified ecosystem for patient identification, study execution, and end-of-study patient communications, according to the vendor. Introduced initially in the U.S., myMedidata Registries will also be available in other countries in the future, the company said.

Greenphire joins clinical trial alliance
Finance lifecycle management firm Greenphire has joined the Decentralized Trials & Research Alliance, a group of 100 life science and healthcare organizations.

Report finds CROs modernizing, accelerating clinical trials
Contract research organizations (CROs) are modernizing and speeding up clinical trials with 90% unifying their clinical operations, according to a new...

Researchers innovate drug discovery screening techniques
Researchers from around the globe gathered to discuss innovations in laboratory techniques such as phenotypic profiling and flow cytometry for drug discovery...

Clinical trial imaging market to grow to $1.4B by 2028
The global clinical trial imaging market is projected to reach $1.4 billion by 2028, according a new report by Grand View Research.